Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Venaxis APPY

Healthcare Diagnostics & Research
"Venaxis Inc is engaged in the development and commercialization of products that address unmet diagnostic and therapeutic needs. Its activities have been focused on human acute appendicitis blood-based test."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:APPY)

Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to "BIOP" from "APPY"

PR Newswire December 8, 2016

Top Performing Industries For October 7, 2016

Benzinga.com  October 7, 2016

Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire September 23, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  September 14, 2016

Mid-Day Market Update: Crude Oil Down Over 2%; Vitae Pharmaceuticals Shares Surge Following Allergan Buyout

Benzinga.com  September 14, 2016

Venaxis Announces Termination of Proposed Transactions with Strand Life Sciences

PR Newswire March 14, 2016

Venaxis Announces Transaction with Strand Life Sciences

PR Newswire January 26, 2016

Venaxis Business Update

PR Newswire June 22, 2015

Venaxis to Provide Business Update

PR Newswire April 6, 2015
View More News ››

Opinion & Analysis (NDAQ:APPY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:APPY)

make the move

http://www.kijiji.ca/v-friendship-networking/city-of-toronto/sunny-dehghan/1221057712?enableSearchNavigationFlag=true
jomby - December 2, 2016

Venaxis Stock Price Falls (Name Change)

AspenBio Inc. has changed its name to Venaxis which has dumped the stock by more than 2.5% today. Traders who have purchased stocks...
AnalystGrimes - December 24, 2012

APPY..........///

People were watching APPY on Monday as it made some big gains. They were going to talk about it but the...
mark897 - October 27, 2010

Mark To Mark

Those mark to market valuations sure took some by surprise.  Amazing that they are allowed to shrink down that low.
biovine811 - March 13, 2009
View more Bullboard ››

Cascadia Minerals Ltd

Cascadia Minerals Ltd

Cascadia is a Canadian junior mining company focused on exploring for copper and gold in the Yukon and British Columbia ...
View More »